Tetsuya Mitarai

FP227CLINICAL SIGNIFICANCE OF MIZORIBINE IN ELDERLY PATIENTS WITH PRIMARY MEMBRANOUS NEPHROPATHY

Hajime Hasegawa, Tetsuya Mitarai, Yasuhiko Tomino, Hitoshi Yokoyama et autres

INTRODUCTION: Membranous nephropathy (MN) is known to affect frequently in elderly patients and its initial therapeutic strategy in Japan is sole administration of Prednisolone (PSL) of 1 mg/kg for 4 weeks, and concomitant use of immunosuppressant such as Cyclosporin would be considered …

jp (code pays fourni par la source)

Dialysate Purification After Introduction of Automated Hot Water Disinfection System to Central Dialysis Fluid Delivery System

Tomonari Ogawa, Akihiko Matsuda, Yumiko Yamaguchi, Yusuke Sasaki et autres

Most dialysis clinics in Japan have mainly adopted the central dialysis fluid delivery system (CDDS) to provide constant treatment to many patients. Chemical disinfection is the major maintenance method of the CDDS. Our clinic introduced an automated hot water disinfection system that …

jp (code pays fourni par la source)

Front & Back Matter

Irene Brenna, Elisa Volpi, Diego Brancaccio, Mario Cozzolino et autres

Contribution of Residual Renal Function on Peritoneal Solute Transport in Dialysis Patients

Akihiko Matsuda, Osamu Matsumura, Tomonari Ogawa, Yousuke Tayama et autres

BACKGROUND: Increased peritoneal solute transport rate (PSTR) is primarily a consequence of continuous exposure to bioincompatible glucose-based peritoneal dialysis (PD) solutions. However, relationships between increasing PSTR and dialysate glucose load remain unclear. As some PD patients with preserved residual renal function do …

jp (code pays fourni par la source)

[Immunosuppressive therapies for refractory nephrotic syndrome].

Tetsuya Mitarai

[Predictive value of ultrasonographical assessments of carotid artery for cardiovascular events in patients under hemodialysis: add on comparison with stroke patients].

Satoko Nakamura, Rika Kono, Akihiko Matsuda, Osamu Matsumura et autres

BACKGROUND: The prognosis of patients on hemodialysis (HD) was determined with respect to cardiovascular disease. We analyzed the relationships between several parameters of carotid artery echograms and cardiovascular events (CVE) in patients on HD. We also compared the characteristic findings of carotid …

jp (code pays fourni par la source)

The essence of treatment for CKD patients

Y Ando, Sadayoshi Ito, Osamu Uemura, Tetsuo Kato et autres

jp (code pays fourni par la source)

Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease

Seiichi Matsuo, Tsuyoshi Watanabe, Yasuhiko Iino, Shunya Uchida et autres

Evaluation of indications for long-term vascular catheter

Tomonari Ogawa, Etsuko T. Harada, Yuki Kanayama, Ayako Hoshi et autres

長期型バスキュラーカテーテル（VC）の恒久的なバスキュラーアクセス（VA）に規定しない使用方法を検討した．対象症例は，全身状態不良な腎不全患者47例（男26例，女21例）で，急性腎不全（ARF）21症例，慢性腎不全（CRF）26症例（導入例16例，慢性透析患者10例）であった．平均年齢は66±14歳，平均血清アルブミン値（Alb）は2.37±0.54 g/dL，CRPは5.14±5.36 mg/dLであった．長期型VCの使用本数は48本で，留置部位は右内頸静脈44例，左内頸静脈3例，左鎖骨下静脈1例で，平均留置期間は49.5±56日であった．長期型VCの転帰は，内シャント（AVF）作製による抜去16例，死亡16例（悪性腫瘍関連死9例，敗血症7例），感染徴候による抜去5例，透析離脱4例，閉塞・脱血不良2例，継続2例などであった．AVF造設，死亡，透析離脱を除いた長期型VCの開存率は，挿入後30日で約80％，90日でも約60％あった．全身状態不良なARFおよびCRF症例に長期型VCを使用することで，平均7週間の安定した血液透析療法が施行できた．長期型VCは恒久的なVAとしての適応以外に，早期のAVF作製困難なCRF症例におけるbridging VAおよび短期間での透析離脱が難しいARF症例などのVAとしても有用と考えられた．

jp, gb (code pays fourni par la source)

Subject Index Vol. 77, 1997

Ryuji Nagasawa, Koichi Kanozawa, Tetsuya Mitarai, Masaki Inagaki et autres

Acknowledgement to the Reviewers

Ryuji Nagasawa, Koichi Kanozawa, Tetsuya Mitarai, Masaki Inagaki et autres

Contents, Vol. 70, 1995

Akio Nakamura, Teruaki Suzuki, Takao Kohsaka, Natale G. DeSanto et autres